Ceftazidime + Avibactam

Category: Antibiotics



Ceftazidime + Avibactam Overview

Avibactam is a non-β-lactam β-lactamase inhibitor[2] developed by Actavis (now Teva) jointly with AstraZeneca. A new drug application for avibactam in combination with ceftazidime (branded as Avycaz) was approved by the FDA on February 25, 2015, for treating complicated urinary tract (cUTI) and complicated intra-abdominal infections (cIAI) caused by antibiotic resistant-pathogens, including those caused by multi-drug resistant Gram-negative bacterial pathogens.&#...

Read more Ceftazidime + Avibactam Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Avibactam

Recent Ceftazidime + Avibactam Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Ceftazidime + Avibactam
  • Injection: 2g + 0.5g
  • Powder: 0.5gm + 2gm/vial
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Drugs with one or more similar ingredients: (6 results)

Related Ceftazidime + Avibactam Topics:

CEFTAZIDIME PRODUCT MONOGRAPH
PLEASE CEFTAZIDIME complete information as early as possible. ## Ceftazidime is usually reserved for the treatment of in... 1 reply




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 1 June 2020.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA